BioSpace News Archive

Drug Development

Texas A&M Drug Shows Promise Against Multiple Respiratory Infections

Researchers believe the drug PUL-042 may work against COVID-19 and other respiratory infections, including all existing and future variants of SARS-CoV-2.

October 28, 2021
·
2 min read
·
Mark Terry
Policy

Novartis Under New DOJ Scrutiny Over Potential Kickback Allegations

Novartis is the subject of a DOJ inquiry over the company’s marketing and pricing of Entresto over the past five years, receiving a Civil Investigative Demand from the government.

October 28, 2021
·
3 min read
·
Alex Keown
Business

Alnylam’s Maraganore Stepping Down; Harpoon Taps New CEO

Alnylam Chief Executive Officer Dr. John Maraganore, who has guided the company’s RNAi therapies from concept to commercialization, is handing over the reins of the company at the end of the year.

October 28, 2021
·
3 min read
·
Alex Keown
Drug Development

Positive Results in Hand, AbbVie Eyes Potential Approval for Parkinson’s Treatment

AbbVie’s experimental subcutaneous Parkinson’s disease drug ABBV-951 hit the mark in a 12-week Phase III study in patients with an advanced form of the disease.

October 28, 2021
·
2 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, Oct. 29

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

October 28, 2021
·
7 min read
·
Alex Keown
Policy

CytoDyn Announces FDA Accepts Revised Rolling Review Timeline for Resubmission of its BLA

CytoDyn Inc. announced the U.S. Food and Drug Administration has accepted the Company’s revised “Rolling Review” timeline for the Company’s upcoming resubmission of its Biologics License Application for leronlimab as a combination therapy for highly treatment experienced HIV patients.

October 28, 2021
·
10 min read
Deals

MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs in the United States

MDxHealth SA, a commercial-stage precision diagnostics company, announced that it is launching a registered initial public offering of 3,750,000 American Depositary Shares .

October 28, 2021
·
5 min read
Commercial Adoption of Herdscreen® ASFV Antibody Test in Europe

Algenex SL and Global Dx Ltd announce the adoption of Herdscreen® ASFV Antibody Test by a major Spanish producer of pig-derived food and meat.

October 28, 2021
·
4 min read
Business

argenx Reports Third Quarter 2021 Financial Results and Provides Business Update

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced its third quarter 2021 financial results and provided a business update and outlook for the remainder of the year.

October 28, 2021
·
15 min read
Therapeutic Vaccines Market: Rise in the prevalence of various chronic diseases to drive the market

The global market for therapeutic vaccines is witnessing a phase of significant growth. Thanks to the efficiency of these vaccines, an upsurge in their demand is likely to continue over the next few years.

October 28, 2021
·
6 min read